Biotechnology Assets S.A. (BST) — Capital Reinvestment Ratio
Latest as of June 2025:
0.00x
Biotechnology Assets S.A. (BST) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (€658.13K) in capital expenditures (€1.99K). See Biotechnology Assets S.A. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
€658.13K
EUR
Capital Expenditures
€1.99K
EUR
Data as of
Jun 2025
Most recent filing
Biotechnology Assets S.A. Capital Reinvestment Ratio (2015–2023)
This chart tracks Biotechnology Assets S.A.'s Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Biotechnology Assets S.A. (2015–2023)
Year-by-year Capital Reinvestment Ratio for Biotechnology Assets S.A. from 2015 to 2023. For live market cap and broader valuation context, see how much is Biotechnology Assets S.A. worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.83x | €47.74K | €325.97K | ▲ +15235.3% |
| 2020 | 0.04x | €8.79 Million | €391.53K | ▼ -99.4% |
| 2017 | 7.33x | €213.49K | €1.56 Million | ▲ +508.5% |
| 2016 | 1.20x | €2.71 Million | €3.27 Million | ▼ -82.2% |
| 2015 | 6.75x | €158.16K | €1.07 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow